Phase 2 Gout Trial, Recruiting NCT06924658 Sponsor: Mostafa Bahaa Condition: Gout
Back to Gout

Phase 2 Gout Trial, Recruiting

NCT06924658
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with gouty arthritis (a type of gout that causes painful joint inflammation) by a doctor, using standard international diagnostic guidelines.

Who may not be able to join:

  • You have a serious condition affecting your whole body, such as heart disease, neurological (nervous system) conditions, or coronary artery disease (blocked arteries to the heart).
  • You have high blood pressure, high cholesterol, diabetes, or an active infection.
  • You have another inflammatory or autoimmune disease (a condition where your immune system attacks your own body).
  • You are currently taking biologic medications (a type of drug made from living cells, often used for immune system conditions).
  • You have had an allergic reaction to metformin (a common diabetes medication), or you have problems with your liver or kidneys.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Mostafa Bahaa
Registry
ClinicalTrials.gov
Start date
20 April 2025
Est. completion
20 November 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

- Clinical assessment of disease activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov